Oncothyreon to Present at Lazard Capital Markets Healthcare Conference
SEATTLE, WA, Nov. 8, 2011 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that the company will be presenting at the Lazard Capital Markets 8th Annual Healthcare Conference in New York on Tuesday, November 15, 2011 at 9:30 a.m. Eastern Standard Time.
A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Share this article